I picked F stock (Ford). Lets see if i can come in last

New Post Public Reply Private Reply Replies (0) Message Board
joey68
407
I picked F stock (Ford). Lets see if i can come in last place haha
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Samuel Oschin Center Opens, Promising Wonder

Updated Category News Views 179

A Grand New Space for Space Well, here's a sight for sore eyes—California Science Center's Samuel Oschin Air and Space Center just swung its doors open wide, and boy, it's a beast of a place. Housing a spectacle like the Space Shuttle Endeavour in a vertical launch position, it's as if they've reached up and snagged a piece of the sky itself for their exhibits. They're...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 133

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 171

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 161

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Euroandinos Paita Closes Consent for 2037 Notes

Updated Category News Views 122

Port Strategy and Financial Implications Terminales Portuarios Euroandinos Paita S.A., nestled in the Peruvian transport sector, has been tight-rope walking through its debt landscape. Announcing a successful consent solicitation on November 13, 2026, they've taken a significant step towards reconfiguring their long-term financing game. This puppet show of paperwork...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 175

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
vVARDIS Debuts on NYSE: Transforming Dental Care

Updated Category News Views 92

A New Chapter for Dental Tech Mark your calendars, folks. vVARDIS is stepping onto the New York Stock Exchange (NYSE) stage, waving the banner of NYSE:VVVV. Now, if you've ever sat in that squeaky dental chair feeling the dread of a drill, vVARDIS might just be the new hero in town. Founded by the dynamic duo, Dr. Haley and Dr. Goly Abivardi, they're on a mission to...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 94

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 170

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Accuray Finishes Key Deal, Resetting Financial Trajectory

Updated Category News Views 136

Accuray Secures the Deal, But Is the Future Bright? Every now and then in the investing world, a company pulls off a maneuver that you wish you’d thought of first. Today, folks, it's Accuray's turn. They've just wrapped up a monstrous transaction with TCW – their primary lender and shareholder – that has them feeling optimistic about the road ahead. Bold Moves to...

Continue Reading

Top 5 Most Recently Viewed Articles

Under Armour and UNLESS: A New Era in Sustainable Sportswear

Updated Category News Views 185

Under Armour and UNLESS Unveil Groundbreaking Sportswear Innovative Launch at Milan Design Week Under Armour, Inc. and UNLESS, Inc. are set to revolutionize the sportswear industry by introducing a remarkable regenerative sportswear collection during Milan Design Week. This innovative project is a significant milestone representing their first collaboration, focusing on...

Continue Reading
Primech Holdings Expands Reach in North America, Targets Growth

Updated Category News Views 111

Primech Holdings Expands Presence in North America Primech Holdings Limited (NASDAQ: PMEC) has marked a significant milestone by opening its United States office in Edwardsville, Illinois. This expansion into North America is driven by the increasing demand for advanced, AI-driven cleaning solutions among institutional clients. Strategic Location for Growth Illinois was...

Continue Reading
Quantum Computing Inc. Secures $500 Million Through Private Placement

Updated Category News Views 296

Quantum Computing Inc. Strengthens Financial Backbone Quantum Computing Inc. (NASDAQ: QUBT), a pioneering company in the realm of integrated photonics and quantum optics technologies, has made headlines with its significant financing move. Recently, QCi announced that it has successfully arranged a private placement of common stock, amassing $500 million. This capital...

Continue Reading
Glaukos Takes Major Step with Epioxa™ FDA Application

Updated Category News Views 80

Glaukos Takes Major Step with Epioxa™ FDA Application Glaukos Corporation (NYSE: GKOS), a distinguished ophthalmic pharmaceutical and medical technology enterprise, has made significant strides by filing a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for Epioxa™, its state-of-the-art keratoconus therapy. This innovative treatment...

Continue Reading
Freshpet's Upcoming Q1 2025 Results and Company Growth Insights

Updated Category News Views 222

Freshpet to Share First Quarter Results for 2025 Freshpet, Inc. is set to disclose its financial results for the first quarter concluding on March 31, 2025. The announcement is scheduled for the morning of May 5, 2025, just before the market opens. As a public company operating under Nasdaq: FRPT, Freshpet has garnered significant attention in the pet food industry....

Continue Reading